Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for TFAP2B
Z-value: 2.66
Motif logo
Transcription factors associated with TFAP2B
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
TFAP2B
|
ENSG00000008196.8 | transcription factor AP-2 beta |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| TFAP2B | hg19_v2_chr6_+_50786414_50786439 | -0.27 | 2.4e-01 | Click! |
Activity profile of TFAP2B motif
Sorted Z-values of TFAP2B motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr12_-_52914155 | 18.68 |
ENST00000549420.1
ENST00000551275.1 ENST00000546577.1 |
KRT5
|
keratin 5 |
| chr17_-_39677971 | 11.82 |
ENST00000393976.2
|
KRT15
|
keratin 15 |
| chr13_-_107187462 | 9.92 |
ENST00000245323.4
|
EFNB2
|
ephrin-B2 |
| chr1_-_153588334 | 9.85 |
ENST00000476873.1
|
S100A14
|
S100 calcium binding protein A14 |
| chr16_+_68679193 | 9.79 |
ENST00000581171.1
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
| chr16_+_68678892 | 9.77 |
ENST00000429102.2
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
| chr21_-_28217721 | 9.30 |
ENST00000284984.3
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
| chr1_+_152881014 | 9.25 |
ENST00000368764.3
ENST00000392667.2 |
IVL
|
involucrin |
| chr1_+_32042131 | 8.93 |
ENST00000271064.7
ENST00000537531.1 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
| chr1_+_32042105 | 8.66 |
ENST00000457433.2
ENST00000441210.2 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
| chr6_+_54711533 | 7.62 |
ENST00000306858.7
|
FAM83B
|
family with sequence similarity 83, member B |
| chr14_+_94640633 | 6.98 |
ENST00000304338.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
| chr1_+_209602771 | 6.88 |
ENST00000440276.1
|
MIR205HG
|
MIR205 host gene (non-protein coding) |
| chr8_-_143867946 | 6.75 |
ENST00000301263.4
|
LY6D
|
lymphocyte antigen 6 complex, locus D |
| chr1_+_2398876 | 6.25 |
ENST00000449969.1
|
PLCH2
|
phospholipase C, eta 2 |
| chr12_-_89746173 | 6.16 |
ENST00000308385.6
|
DUSP6
|
dual specificity phosphatase 6 |
| chr9_-_21974820 | 6.06 |
ENST00000579122.1
ENST00000498124.1 |
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
| chr9_-_21975088 | 6.00 |
ENST00000304494.5
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
| chr2_+_208104351 | 5.98 |
ENST00000440326.1
|
AC007879.7
|
AC007879.7 |
| chr1_+_160370344 | 5.80 |
ENST00000368061.2
|
VANGL2
|
VANGL planar cell polarity protein 2 |
| chr19_-_11689752 | 5.64 |
ENST00000592659.1
ENST00000592828.1 ENST00000218758.5 ENST00000412435.2 |
ACP5
|
acid phosphatase 5, tartrate resistant |
| chr10_+_71078595 | 5.62 |
ENST00000359426.6
|
HK1
|
hexokinase 1 |
| chr1_+_209602609 | 5.62 |
ENST00000458250.1
|
MIR205HG
|
MIR205 host gene (non-protein coding) |
| chr15_+_101420028 | 5.55 |
ENST00000557963.1
ENST00000346623.6 |
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3 |
| chr7_-_143105941 | 5.54 |
ENST00000275815.3
|
EPHA1
|
EPH receptor A1 |
| chr12_-_57634475 | 5.49 |
ENST00000393825.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
| chr16_-_68269971 | 5.43 |
ENST00000565858.1
|
ESRP2
|
epithelial splicing regulatory protein 2 |
| chr2_+_208104497 | 5.39 |
ENST00000430494.1
|
AC007879.7
|
AC007879.7 |
| chr19_-_19739007 | 5.34 |
ENST00000586703.1
ENST00000591042.1 ENST00000407877.3 |
LPAR2
|
lysophosphatidic acid receptor 2 |
| chr17_-_5487768 | 5.29 |
ENST00000269280.4
ENST00000345221.3 ENST00000262467.5 |
NLRP1
|
NLR family, pyrin domain containing 1 |
| chr12_-_15114603 | 5.06 |
ENST00000228945.4
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
| chr6_+_43112037 | 5.06 |
ENST00000473339.1
|
PTK7
|
protein tyrosine kinase 7 |
| chr3_-_52090461 | 4.99 |
ENST00000296483.6
ENST00000495880.1 |
DUSP7
|
dual specificity phosphatase 7 |
| chr16_+_30907927 | 4.96 |
ENST00000279804.2
ENST00000395019.3 |
CTF1
|
cardiotrophin 1 |
| chr18_+_33877654 | 4.92 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
| chr5_+_148521381 | 4.88 |
ENST00000504238.1
|
ABLIM3
|
actin binding LIM protein family, member 3 |
| chr1_-_27339317 | 4.80 |
ENST00000289166.5
|
FAM46B
|
family with sequence similarity 46, member B |
| chr12_-_123380610 | 4.57 |
ENST00000535765.1
|
VPS37B
|
vacuolar protein sorting 37 homolog B (S. cerevisiae) |
| chr11_+_131781290 | 4.36 |
ENST00000425719.2
ENST00000374784.1 |
NTM
|
neurotrimin |
| chr3_+_100211412 | 4.35 |
ENST00000323523.4
ENST00000403410.1 ENST00000449609.1 |
TMEM45A
|
transmembrane protein 45A |
| chr19_-_37341160 | 4.21 |
ENST00000528994.1
|
ZNF790
|
zinc finger protein 790 |
| chr20_+_62327996 | 4.07 |
ENST00000369996.1
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy |
| chr21_-_45078019 | 4.00 |
ENST00000542962.1
|
HSF2BP
|
heat shock transcription factor 2 binding protein |
| chr3_-_48470838 | 3.97 |
ENST00000358459.4
ENST00000358536.4 |
PLXNB1
|
plexin B1 |
| chr11_-_61348576 | 3.93 |
ENST00000263846.4
|
SYT7
|
synaptotagmin VII |
| chr15_+_78556809 | 3.93 |
ENST00000343789.3
ENST00000394852.3 |
DNAJA4
|
DnaJ (Hsp40) homolog, subfamily A, member 4 |
| chr17_+_42429493 | 3.90 |
ENST00000586242.1
|
GRN
|
granulin |
| chr17_+_7758374 | 3.78 |
ENST00000301599.6
ENST00000574668.1 |
TMEM88
|
transmembrane protein 88 |
| chr1_-_6321035 | 3.70 |
ENST00000377893.2
|
GPR153
|
G protein-coupled receptor 153 |
| chr5_+_148521136 | 3.69 |
ENST00000506113.1
|
ABLIM3
|
actin binding LIM protein family, member 3 |
| chr4_-_83719983 | 3.61 |
ENST00000319540.4
|
SCD5
|
stearoyl-CoA desaturase 5 |
| chr11_-_7695437 | 3.60 |
ENST00000533558.1
ENST00000527542.1 ENST00000531096.1 |
CYB5R2
|
cytochrome b5 reductase 2 |
| chr12_-_15114492 | 3.58 |
ENST00000541546.1
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
| chr17_-_4463856 | 3.57 |
ENST00000574584.1
ENST00000381550.3 ENST00000301395.3 |
GGT6
|
gamma-glutamyltransferase 6 |
| chr19_+_35645817 | 3.57 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
| chr12_-_15114191 | 3.54 |
ENST00000541380.1
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
| chr1_+_40506392 | 3.54 |
ENST00000414893.1
ENST00000414281.1 ENST00000420216.1 ENST00000372792.2 ENST00000372798.1 ENST00000340450.3 ENST00000372805.3 ENST00000435719.1 ENST00000427843.1 ENST00000417287.1 ENST00000424977.1 ENST00000446031.1 |
CAP1
|
CAP, adenylate cyclase-associated protein 1 (yeast) |
| chr19_+_35645618 | 3.50 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
| chr5_+_148521046 | 3.49 |
ENST00000326685.7
ENST00000356541.3 ENST00000309868.7 |
ABLIM3
|
actin binding LIM protein family, member 3 |
| chr1_-_9189229 | 3.47 |
ENST00000377411.4
|
GPR157
|
G protein-coupled receptor 157 |
| chr14_+_72052983 | 3.42 |
ENST00000358550.2
|
SIPA1L1
|
signal-induced proliferation-associated 1 like 1 |
| chr1_-_27286897 | 3.41 |
ENST00000320567.5
|
C1orf172
|
chromosome 1 open reading frame 172 |
| chr7_+_75932863 | 3.34 |
ENST00000429938.1
|
HSPB1
|
heat shock 27kDa protein 1 |
| chr2_-_220408430 | 3.30 |
ENST00000243776.6
|
CHPF
|
chondroitin polymerizing factor |
| chr1_-_31902614 | 3.29 |
ENST00000596131.1
|
AC114494.1
|
HCG1787699; Uncharacterized protein |
| chr17_+_7255208 | 3.27 |
ENST00000333751.3
|
KCTD11
|
potassium channel tetramerization domain containing 11 |
| chr9_+_112542591 | 3.23 |
ENST00000483909.1
ENST00000314527.4 ENST00000413420.1 ENST00000302798.7 ENST00000555236.1 ENST00000510514.5 |
PALM2
PALM2-AKAP2
AKAP2
|
paralemmin 2 PALM2-AKAP2 readthrough A kinase (PRKA) anchor protein 2 |
| chr11_-_7694684 | 3.20 |
ENST00000524790.1
ENST00000299497.9 ENST00000299498.6 |
CYB5R2
|
cytochrome b5 reductase 2 |
| chr19_-_19739321 | 3.19 |
ENST00000588461.1
|
LPAR2
|
lysophosphatidic acid receptor 2 |
| chr1_+_40506255 | 3.18 |
ENST00000421589.1
|
CAP1
|
CAP, adenylate cyclase-associated protein 1 (yeast) |
| chr14_+_94640671 | 3.16 |
ENST00000328839.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
| chr14_-_91720224 | 3.10 |
ENST00000238699.3
ENST00000531499.2 |
GPR68
|
G protein-coupled receptor 68 |
| chr15_+_78556428 | 3.10 |
ENST00000394855.3
ENST00000489435.2 |
DNAJA4
|
DnaJ (Hsp40) homolog, subfamily A, member 4 |
| chr3_+_42544084 | 3.01 |
ENST00000543411.1
ENST00000438259.2 ENST00000439731.1 ENST00000325123.4 |
VIPR1
|
vasoactive intestinal peptide receptor 1 |
| chr16_+_2867164 | 2.98 |
ENST00000455114.1
ENST00000450020.3 |
PRSS21
|
protease, serine, 21 (testisin) |
| chr15_+_96873921 | 2.97 |
ENST00000394166.3
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
| chr11_-_7694974 | 2.96 |
ENST00000436351.2
|
CYB5R2
|
cytochrome b5 reductase 2 |
| chr6_-_35464727 | 2.95 |
ENST00000402886.3
|
TEAD3
|
TEA domain family member 3 |
| chr6_-_35464817 | 2.94 |
ENST00000338863.7
|
TEAD3
|
TEA domain family member 3 |
| chr12_-_89746264 | 2.94 |
ENST00000548755.1
|
DUSP6
|
dual specificity phosphatase 6 |
| chr12_-_48152428 | 2.90 |
ENST00000449771.2
ENST00000395358.3 |
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
| chr5_+_148521454 | 2.90 |
ENST00000508983.1
|
ABLIM3
|
actin binding LIM protein family, member 3 |
| chr7_-_27169801 | 2.89 |
ENST00000511914.1
|
HOXA4
|
homeobox A4 |
| chr16_+_2867228 | 2.87 |
ENST00000005995.3
ENST00000574813.1 |
PRSS21
|
protease, serine, 21 (testisin) |
| chr1_-_21503337 | 2.86 |
ENST00000400422.1
ENST00000602326.1 ENST00000411888.1 ENST00000438975.1 |
EIF4G3
|
eukaryotic translation initiation factor 4 gamma, 3 |
| chr10_-_5638048 | 2.86 |
ENST00000478294.1
|
RP13-463N16.6
|
RP13-463N16.6 |
| chr2_-_222436988 | 2.85 |
ENST00000409854.1
ENST00000281821.2 ENST00000392071.4 ENST00000443796.1 |
EPHA4
|
EPH receptor A4 |
| chr16_+_22825475 | 2.84 |
ENST00000261374.3
|
HS3ST2
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 2 |
| chr3_+_10857885 | 2.84 |
ENST00000254488.2
ENST00000454147.1 |
SLC6A11
|
solute carrier family 6 (neurotransmitter transporter), member 11 |
| chr10_+_135340859 | 2.84 |
ENST00000252945.3
ENST00000421586.1 ENST00000418356.1 |
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1 |
| chr3_-_183145873 | 2.80 |
ENST00000447025.2
ENST00000414362.2 ENST00000328913.3 |
MCF2L2
|
MCF.2 cell line derived transforming sequence-like 2 |
| chr14_+_65171099 | 2.79 |
ENST00000247226.7
|
PLEKHG3
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
| chr19_+_45971246 | 2.76 |
ENST00000585836.1
ENST00000417353.2 ENST00000353609.3 ENST00000591858.1 ENST00000443841.2 ENST00000590335.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
| chr6_-_35888824 | 2.70 |
ENST00000361690.3
ENST00000512445.1 |
SRPK1
|
SRSF protein kinase 1 |
| chr16_-_75498450 | 2.66 |
ENST00000566594.1
|
RP11-77K12.1
|
Uncharacterized protein |
| chr1_+_33207381 | 2.66 |
ENST00000401073.2
|
KIAA1522
|
KIAA1522 |
| chr3_-_49459865 | 2.64 |
ENST00000427987.1
|
AMT
|
aminomethyltransferase |
| chr9_+_124030338 | 2.61 |
ENST00000449773.1
ENST00000432226.1 ENST00000436847.1 ENST00000394353.2 ENST00000449733.1 ENST00000412819.1 ENST00000341272.2 ENST00000373808.2 |
GSN
|
gelsolin |
| chr11_-_61348292 | 2.60 |
ENST00000539008.1
ENST00000540677.1 ENST00000542836.1 ENST00000542670.1 ENST00000535826.1 ENST00000545053.1 |
SYT7
|
synaptotagmin VII |
| chr6_-_30654977 | 2.58 |
ENST00000399199.3
|
PPP1R18
|
protein phosphatase 1, regulatory subunit 18 |
| chr10_+_11047259 | 2.57 |
ENST00000379261.4
ENST00000416382.2 |
CELF2
|
CUGBP, Elav-like family member 2 |
| chr4_-_1723040 | 2.53 |
ENST00000382936.3
ENST00000536901.1 ENST00000303277.2 |
TMEM129
|
transmembrane protein 129 |
| chr7_+_65939543 | 2.51 |
ENST00000600021.1
|
AC008267.1
|
HCG1983814; Uncharacterized protein |
| chr14_+_65171315 | 2.48 |
ENST00000394691.1
|
PLEKHG3
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
| chr12_-_112037136 | 2.46 |
ENST00000608853.1
|
ATXN2
|
ataxin 2 |
| chr21_+_37692481 | 2.44 |
ENST00000400485.1
|
MORC3
|
MORC family CW-type zinc finger 3 |
| chr19_-_10679644 | 2.35 |
ENST00000393599.2
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
| chr8_-_11058847 | 2.34 |
ENST00000297303.4
ENST00000416569.2 |
XKR6
|
XK, Kell blood group complex subunit-related family, member 6 |
| chr1_+_158969752 | 2.33 |
ENST00000566111.1
|
IFI16
|
interferon, gamma-inducible protein 16 |
| chrX_+_131157609 | 2.33 |
ENST00000496850.1
|
MST4
|
Serine/threonine-protein kinase MST4 |
| chr3_-_49459878 | 2.30 |
ENST00000546031.1
ENST00000458307.2 ENST00000430521.1 |
AMT
|
aminomethyltransferase |
| chr14_-_69619291 | 2.29 |
ENST00000554215.1
ENST00000556847.1 |
DCAF5
|
DDB1 and CUL4 associated factor 5 |
| chr16_+_2546033 | 2.28 |
ENST00000564543.1
ENST00000434757.2 |
RP11-20I23.1
TBC1D24
|
Uncharacterized protein TBC1 domain family, member 24 |
| chr2_-_222437049 | 2.26 |
ENST00000541600.1
|
EPHA4
|
EPH receptor A4 |
| chr17_-_4464081 | 2.24 |
ENST00000574154.1
|
GGT6
|
gamma-glutamyltransferase 6 |
| chr19_-_37329254 | 2.24 |
ENST00000356725.4
|
ZNF790
|
zinc finger protein 790 |
| chr6_-_47277634 | 2.24 |
ENST00000296861.2
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21 |
| chr3_-_124839648 | 2.21 |
ENST00000430155.2
|
SLC12A8
|
solute carrier family 12, member 8 |
| chr4_-_41216492 | 2.20 |
ENST00000503503.1
ENST00000509446.1 ENST00000503264.1 ENST00000508707.1 ENST00000508593.1 |
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2 |
| chr1_+_17575584 | 2.17 |
ENST00000375460.3
|
PADI3
|
peptidyl arginine deiminase, type III |
| chr12_-_112037306 | 2.16 |
ENST00000535949.1
ENST00000542287.2 ENST00000377617.3 ENST00000550104.1 |
ATXN2
|
ataxin 2 |
| chr19_-_10628117 | 2.16 |
ENST00000333430.4
|
S1PR5
|
sphingosine-1-phosphate receptor 5 |
| chr11_-_63536113 | 2.14 |
ENST00000433688.1
ENST00000546282.2 |
C11orf95
RP11-466C23.4
|
chromosome 11 open reading frame 95 RP11-466C23.4 |
| chr17_+_4901199 | 2.14 |
ENST00000320785.5
ENST00000574165.1 |
KIF1C
|
kinesin family member 1C |
| chr1_-_40782938 | 2.12 |
ENST00000372736.3
ENST00000372748.3 |
COL9A2
|
collagen, type IX, alpha 2 |
| chr19_-_55865908 | 2.08 |
ENST00000590900.1
|
COX6B2
|
cytochrome c oxidase subunit VIb polypeptide 2 (testis) |
| chr16_+_67465016 | 2.07 |
ENST00000326152.5
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2 |
| chr1_+_154377669 | 2.06 |
ENST00000368485.3
ENST00000344086.4 |
IL6R
|
interleukin 6 receptor |
| chr14_-_69619823 | 2.04 |
ENST00000341516.5
|
DCAF5
|
DDB1 and CUL4 associated factor 5 |
| chr11_+_66036004 | 2.02 |
ENST00000311481.6
ENST00000527397.1 |
RAB1B
|
RAB1B, member RAS oncogene family |
| chr13_+_60971427 | 2.02 |
ENST00000535286.1
ENST00000377881.2 |
TDRD3
|
tudor domain containing 3 |
| chr17_+_7748233 | 2.00 |
ENST00000570632.1
|
KDM6B
|
lysine (K)-specific demethylase 6B |
| chr12_+_19282713 | 1.97 |
ENST00000299275.6
ENST00000539256.1 ENST00000538714.1 |
PLEKHA5
|
pleckstrin homology domain containing, family A member 5 |
| chr6_-_138428613 | 1.96 |
ENST00000421351.3
|
PERP
|
PERP, TP53 apoptosis effector |
| chr1_-_20812690 | 1.95 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
| chr19_+_13229126 | 1.94 |
ENST00000292431.4
|
NACC1
|
nucleus accumbens associated 1, BEN and BTB (POZ) domain containing |
| chr5_-_157002749 | 1.94 |
ENST00000517905.1
ENST00000430702.2 ENST00000394020.1 |
ADAM19
|
ADAM metallopeptidase domain 19 |
| chr4_+_78078304 | 1.93 |
ENST00000316355.5
ENST00000354403.5 ENST00000502280.1 |
CCNG2
|
cyclin G2 |
| chr1_+_65613852 | 1.91 |
ENST00000327299.7
|
AK4
|
adenylate kinase 4 |
| chr19_-_55866061 | 1.91 |
ENST00000588572.2
ENST00000593184.1 ENST00000589467.1 |
COX6B2
|
cytochrome c oxidase subunit VIb polypeptide 2 (testis) |
| chr8_+_22435762 | 1.91 |
ENST00000456545.1
|
PDLIM2
|
PDZ and LIM domain 2 (mystique) |
| chr1_+_209929377 | 1.89 |
ENST00000400959.3
ENST00000367025.3 |
TRAF3IP3
|
TRAF3 interacting protein 3 |
| chr10_-_14880566 | 1.89 |
ENST00000378442.1
|
CDNF
|
cerebral dopamine neurotrophic factor |
| chr6_-_34664612 | 1.86 |
ENST00000374023.3
ENST00000374026.3 |
C6orf106
|
chromosome 6 open reading frame 106 |
| chr20_-_50808236 | 1.85 |
ENST00000361387.2
|
ZFP64
|
ZFP64 zinc finger protein |
| chr8_-_30670053 | 1.84 |
ENST00000518564.1
|
PPP2CB
|
protein phosphatase 2, catalytic subunit, beta isozyme |
| chr19_+_10828795 | 1.84 |
ENST00000389253.4
ENST00000355667.6 ENST00000408974.4 |
DNM2
|
dynamin 2 |
| chr11_-_63684316 | 1.83 |
ENST00000301459.4
|
RCOR2
|
REST corepressor 2 |
| chr19_-_19144243 | 1.82 |
ENST00000594445.1
ENST00000452918.2 ENST00000600377.1 ENST00000337018.6 |
SUGP2
|
SURP and G patch domain containing 2 |
| chr4_-_41216619 | 1.82 |
ENST00000508676.1
ENST00000506352.1 ENST00000295974.8 |
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2 |
| chr6_-_3457256 | 1.81 |
ENST00000436008.2
|
SLC22A23
|
solute carrier family 22, member 23 |
| chr5_+_36608422 | 1.80 |
ENST00000381918.3
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
| chr3_-_150481218 | 1.79 |
ENST00000482706.1
|
SIAH2
|
siah E3 ubiquitin protein ligase 2 |
| chr1_+_40505891 | 1.78 |
ENST00000372797.3
ENST00000372802.1 ENST00000449311.1 |
CAP1
|
CAP, adenylate cyclase-associated protein 1 (yeast) |
| chr4_-_87770416 | 1.78 |
ENST00000273905.6
|
SLC10A6
|
solute carrier family 10 (sodium/bile acid cotransporter), member 6 |
| chr7_-_127671674 | 1.77 |
ENST00000478726.1
|
LRRC4
|
leucine rich repeat containing 4 |
| chr3_+_41240925 | 1.76 |
ENST00000396183.3
ENST00000349496.5 ENST00000453024.1 |
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa |
| chr12_+_6308881 | 1.74 |
ENST00000382518.1
ENST00000536586.1 |
CD9
|
CD9 molecule |
| chr2_-_43453734 | 1.74 |
ENST00000282388.3
|
ZFP36L2
|
ZFP36 ring finger protein-like 2 |
| chr12_-_48152853 | 1.72 |
ENST00000171000.4
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
| chr1_+_209929494 | 1.71 |
ENST00000367026.3
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
| chr5_+_131409476 | 1.71 |
ENST00000296871.2
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage) |
| chr3_-_10052849 | 1.70 |
ENST00000437616.1
ENST00000429065.2 |
AC022007.5
|
AC022007.5 |
| chr19_+_7710774 | 1.69 |
ENST00000602355.1
|
STXBP2
|
syntaxin binding protein 2 |
| chr2_+_120770686 | 1.68 |
ENST00000331393.4
ENST00000443124.1 |
EPB41L5
|
erythrocyte membrane protein band 4.1 like 5 |
| chr19_+_11546153 | 1.68 |
ENST00000591946.1
ENST00000252455.2 ENST00000412601.1 |
PRKCSH
|
protein kinase C substrate 80K-H |
| chr17_+_66511540 | 1.67 |
ENST00000588188.2
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha |
| chr19_+_11546093 | 1.67 |
ENST00000591462.1
|
PRKCSH
|
protein kinase C substrate 80K-H |
| chr4_-_185747188 | 1.66 |
ENST00000507295.1
ENST00000504900.1 ENST00000281455.2 ENST00000454703.2 |
ACSL1
|
acyl-CoA synthetase long-chain family member 1 |
| chrX_+_48916497 | 1.63 |
ENST00000496529.2
ENST00000376396.3 ENST00000422185.2 ENST00000603986.1 ENST00000536628.2 |
CCDC120
|
coiled-coil domain containing 120 |
| chr19_+_37742773 | 1.63 |
ENST00000438770.2
ENST00000591116.1 ENST00000592712.1 |
AC012309.5
|
AC012309.5 |
| chr1_-_147245484 | 1.63 |
ENST00000271348.2
|
GJA5
|
gap junction protein, alpha 5, 40kDa |
| chr6_+_43139037 | 1.63 |
ENST00000265354.4
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor) |
| chr13_-_39612176 | 1.63 |
ENST00000352251.3
ENST00000350125.3 |
PROSER1
|
proline and serine rich 1 |
| chr4_+_26862313 | 1.60 |
ENST00000467087.1
ENST00000382009.3 ENST00000237364.5 |
STIM2
|
stromal interaction molecule 2 |
| chr1_-_11322551 | 1.58 |
ENST00000361445.4
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase) |
| chr11_+_8704298 | 1.58 |
ENST00000531978.1
ENST00000524496.1 ENST00000532359.1 ENST00000530022.1 |
RPL27A
|
ribosomal protein L27a |
| chr5_-_157002775 | 1.57 |
ENST00000257527.4
|
ADAM19
|
ADAM metallopeptidase domain 19 |
| chr3_-_185216811 | 1.57 |
ENST00000421852.1
|
TMEM41A
|
transmembrane protein 41A |
| chr13_+_52158610 | 1.57 |
ENST00000298125.5
|
WDFY2
|
WD repeat and FYVE domain containing 2 |
| chr19_-_55866104 | 1.56 |
ENST00000326529.4
|
COX6B2
|
cytochrome c oxidase subunit VIb polypeptide 2 (testis) |
| chr1_-_6260896 | 1.56 |
ENST00000497965.1
|
RPL22
|
ribosomal protein L22 |
| chr4_+_2800722 | 1.56 |
ENST00000508385.1
|
SH3BP2
|
SH3-domain binding protein 2 |
| chr3_+_135684515 | 1.54 |
ENST00000264977.3
ENST00000490467.1 |
PPP2R3A
|
protein phosphatase 2, regulatory subunit B'', alpha |
| chrX_-_1572629 | 1.54 |
ENST00000534940.1
|
ASMTL
|
acetylserotonin O-methyltransferase-like |
| chr1_-_86861660 | 1.54 |
ENST00000486215.1
|
ODF2L
|
outer dense fiber of sperm tails 2-like |
| chr19_+_7701985 | 1.52 |
ENST00000595950.1
ENST00000441779.2 ENST00000221283.5 ENST00000414284.2 |
STXBP2
|
syntaxin binding protein 2 |
| chr5_+_177540444 | 1.52 |
ENST00000274605.5
|
N4BP3
|
NEDD4 binding protein 3 |
| chr9_+_116917807 | 1.51 |
ENST00000356083.3
|
COL27A1
|
collagen, type XXVII, alpha 1 |
| chr2_-_39347524 | 1.51 |
ENST00000395038.2
ENST00000402219.2 |
SOS1
|
son of sevenless homolog 1 (Drosophila) |
| chr1_-_54872059 | 1.51 |
ENST00000371320.3
|
SSBP3
|
single stranded DNA binding protein 3 |
| chr3_+_138067666 | 1.49 |
ENST00000475711.1
ENST00000464896.1 |
MRAS
|
muscle RAS oncogene homolog |
| chr18_+_34409069 | 1.48 |
ENST00000543923.1
ENST00000280020.5 ENST00000435985.2 ENST00000592521.1 ENST00000587139.1 |
KIAA1328
|
KIAA1328 |
| chr12_-_48152611 | 1.47 |
ENST00000389212.3
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
| chr4_-_41216473 | 1.47 |
ENST00000513140.1
|
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2 |
| chr11_+_117198801 | 1.46 |
ENST00000527609.1
ENST00000533570.1 |
CEP164
|
centrosomal protein 164kDa |
| chr2_-_99485825 | 1.45 |
ENST00000423771.1
|
KIAA1211L
|
KIAA1211-like |
| chr1_-_29508321 | 1.43 |
ENST00000546138.1
|
SRSF4
|
serine/arginine-rich splicing factor 4 |
| chr16_-_66959429 | 1.43 |
ENST00000420652.1
ENST00000299759.6 |
RRAD
|
Ras-related associated with diabetes |
| chrX_+_150151824 | 1.40 |
ENST00000455596.1
ENST00000448905.2 |
HMGB3
|
high mobility group box 3 |
Network of associatons between targets according to the STRING database.
First level regulatory network of TFAP2B
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.9 | 19.6 | GO:1902910 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 2.4 | 7.1 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 2.1 | 6.3 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 1.8 | 9.2 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 1.8 | 9.1 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
| 1.8 | 5.3 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 1.7 | 12.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 1.6 | 6.5 | GO:1990927 | vesicle-mediated cholesterol transport(GO:0090119) short-term synaptic potentiation(GO:1990926) calcium ion regulated lysosome exocytosis(GO:1990927) |
| 1.5 | 4.6 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 1.4 | 5.6 | GO:0060166 | olfactory pit development(GO:0060166) |
| 1.3 | 5.1 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 1.2 | 6.1 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 1.2 | 3.6 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 1.1 | 13.1 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 1.1 | 3.2 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 1.0 | 4.9 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.9 | 5.2 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.8 | 3.3 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 0.8 | 2.4 | GO:0003294 | atrial ventricular junction remodeling(GO:0003294) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
| 0.8 | 6.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.7 | 3.0 | GO:0009956 | radial pattern formation(GO:0009956) |
| 0.7 | 2.9 | GO:0061324 | glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
| 0.7 | 5.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.6 | 1.7 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.6 | 2.2 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 0.6 | 9.9 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.5 | 20.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.5 | 1.6 | GO:0060532 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
| 0.5 | 2.2 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
| 0.5 | 5.9 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.5 | 1.6 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.5 | 2.6 | GO:0044858 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 0.5 | 10.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.5 | 5.6 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.5 | 1.5 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.5 | 1.4 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.5 | 2.8 | GO:0010193 | response to ozone(GO:0010193) |
| 0.4 | 1.3 | GO:0070318 | response to anoxia(GO:0034059) positive regulation of G0 to G1 transition(GO:0070318) |
| 0.4 | 1.3 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.4 | 2.2 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.4 | 6.8 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.4 | 9.9 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.4 | 1.2 | GO:0051255 | spindle midzone assembly(GO:0051255) |
| 0.4 | 4.0 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.4 | 3.6 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.3 | 10.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.3 | 3.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.3 | 1.0 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
| 0.3 | 5.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.3 | 0.7 | GO:0071895 | odontoblast differentiation(GO:0071895) |
| 0.3 | 5.8 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.3 | 7.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.3 | 1.5 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
| 0.3 | 2.9 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.3 | 4.6 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
| 0.3 | 1.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.3 | 1.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.3 | 1.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.3 | 4.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.3 | 1.1 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.3 | 2.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.2 | 1.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.2 | 0.7 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
| 0.2 | 2.4 | GO:0070779 | gamma-aminobutyric acid biosynthetic process(GO:0009449) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.2 | 1.3 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.2 | 0.7 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.2 | 1.5 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.2 | 2.5 | GO:2001181 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.2 | 1.0 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.2 | 0.8 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.2 | 3.5 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.2 | 2.8 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.2 | 0.8 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.2 | 1.2 | GO:0006311 | meiotic gene conversion(GO:0006311) |
| 0.2 | 2.4 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.2 | 1.9 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.2 | 0.9 | GO:0035900 | response to isolation stress(GO:0035900) |
| 0.2 | 4.9 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.2 | 1.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.2 | 1.6 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
| 0.2 | 0.5 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.2 | 6.1 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.2 | 1.7 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.2 | 0.8 | GO:0039019 | pronephric nephron development(GO:0039019) |
| 0.2 | 0.8 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.2 | 0.6 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.1 | 0.6 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.1 | 0.3 | GO:0042662 | negative regulation of mesodermal cell fate specification(GO:0042662) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 0.1 | 2.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 | 0.4 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 | 1.7 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.1 | 1.0 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.1 | 2.3 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.1 | 0.7 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.1 | 0.5 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.1 | 1.8 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 | 0.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 | 0.4 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 0.1 | 3.4 | GO:0051412 | response to corticosterone(GO:0051412) |
| 0.1 | 0.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.1 | 1.8 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.1 | 0.7 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
| 0.1 | 9.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.1 | 0.4 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 | 5.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 0.5 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.1 | 0.3 | GO:0071879 | UDP-glucose catabolic process(GO:0006258) positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.1 | 13.9 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.1 | 1.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 | 0.8 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.1 | 0.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 | 0.3 | GO:0070666 | tolerance induction to self antigen(GO:0002513) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
| 0.1 | 1.2 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 | 0.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 | 1.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.1 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.1 | 3.4 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.1 | 10.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.1 | 8.1 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.1 | 1.0 | GO:1904590 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein import(GO:1904590) |
| 0.1 | 0.5 | GO:0071543 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.1 | 0.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) necroptotic signaling pathway(GO:0097527) |
| 0.1 | 1.1 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.1 | 1.8 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 | 1.2 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.1 | 2.0 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 | 3.9 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.1 | 0.7 | GO:1905247 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.1 | 3.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.1 | 0.5 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.1 | 0.7 | GO:0097105 | postsynaptic membrane assembly(GO:0097104) presynaptic membrane assembly(GO:0097105) |
| 0.1 | 0.2 | GO:0050894 | determination of affect(GO:0050894) |
| 0.1 | 1.9 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 0.1 | 0.5 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 | 1.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.1 | 0.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 | 9.6 | GO:0070268 | cornification(GO:0070268) |
| 0.1 | 0.8 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.1 | 3.6 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 | 0.5 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.1 | 1.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
| 0.1 | 2.6 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 | 2.8 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.1 | 2.6 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 | 0.9 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 | 2.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.1 | 0.2 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.1 | 0.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 0.3 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.1 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 | 1.0 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.1 | 0.1 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 0.0 | 1.2 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.0 | 2.3 | GO:0032731 | positive regulation of interleukin-1 beta production(GO:0032731) |
| 0.0 | 1.7 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 | 0.3 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.0 | 0.4 | GO:0033590 | response to cobalamin(GO:0033590) cellular response to erythropoietin(GO:0036018) |
| 0.0 | 0.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.0 | 0.5 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.0 | 1.0 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.0 | 0.4 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 | 1.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.0 | 0.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 | 0.1 | GO:0003192 | mitral valve formation(GO:0003192) |
| 0.0 | 0.8 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
| 0.0 | 0.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 0.0 | 0.2 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.0 | 6.1 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
| 0.0 | 0.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.0 | 0.4 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.0 | 1.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.0 | 0.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.0 | 6.7 | GO:0001764 | neuron migration(GO:0001764) |
| 0.0 | 1.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.0 | 0.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.0 | 0.7 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.0 | 1.1 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.0 | 2.5 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 | 0.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.0 | 0.7 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 | 2.9 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
| 0.0 | 0.4 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.0 | 0.6 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
| 0.0 | 3.2 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
| 0.0 | 0.4 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.0 | 2.4 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 | 0.6 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 | 0.8 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.0 | 4.0 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.0 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.0 | 0.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 | 10.5 | GO:0016197 | endosomal transport(GO:0016197) |
| 0.0 | 1.5 | GO:0032259 | methylation(GO:0032259) |
| 0.0 | 0.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.0 | 0.3 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
| 0.0 | 1.0 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.0 | 0.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
| 0.0 | 0.5 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
| 0.0 | 0.6 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
| 0.0 | 0.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.0 | 3.0 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.0 | 0.5 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.0 | 0.2 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
| 0.0 | 1.4 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
| 0.0 | 0.0 | GO:0071315 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.0 | 0.2 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.0 | 1.7 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 | 0.9 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.0 | 2.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 | 0.9 | GO:0060348 | bone development(GO:0060348) |
| 0.0 | 0.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.0 | 1.9 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
| 0.0 | 1.6 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
| 0.0 | 1.9 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 0.0 | 0.8 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
| 0.0 | 0.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.0 | 0.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.0 | 0.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.0 | 0.2 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 | 0.8 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.0 | 0.4 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.0 | 2.2 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
| 0.0 | 0.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.0 | 0.1 | GO:0001707 | mesoderm formation(GO:0001707) mesoderm morphogenesis(GO:0048332) |
| 0.0 | 2.0 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.0 | 0.1 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.0 | 0.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
| 0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 | 0.7 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
| 0.0 | 1.0 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
| 0.0 | 0.2 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.0 | 0.2 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
| 0.0 | 0.5 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
| 0.0 | 0.9 | GO:0000045 | autophagosome assembly(GO:0000045) |
| 0.0 | 0.3 | GO:0002209 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
| 0.0 | 2.0 | GO:0006024 | glycosaminoglycan biosynthetic process(GO:0006024) |
| 0.0 | 0.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.0 | 0.3 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 5.8 | GO:0060187 | cell pole(GO:0060187) |
| 1.1 | 13.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.8 | 5.3 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.5 | 6.5 | GO:0032009 | early phagosome(GO:0032009) |
| 0.4 | 5.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.4 | 5.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.4 | 2.9 | GO:0070369 | Scrib-APC-beta-catenin complex(GO:0034750) beta-catenin-TCF7L2 complex(GO:0070369) |
| 0.4 | 2.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.3 | 3.1 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.3 | 2.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.3 | 2.3 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.3 | 4.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.3 | 1.4 | GO:0005606 | laminin-1 complex(GO:0005606) |
| 0.3 | 1.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.3 | 4.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.3 | 0.8 | GO:0097444 | spine apparatus(GO:0097444) |
| 0.2 | 0.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.2 | 1.4 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.2 | 16.5 | GO:0045095 | keratin filament(GO:0045095) |
| 0.2 | 2.6 | GO:0030478 | actin cap(GO:0030478) |
| 0.2 | 2.5 | GO:0045179 | apical cortex(GO:0045179) |
| 0.2 | 0.2 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.2 | 2.0 | GO:0030057 | desmosome(GO:0030057) |
| 0.1 | 1.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.1 | 13.7 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
| 0.1 | 9.6 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.1 | 5.6 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.1 | 0.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.1 | 5.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.1 | 1.9 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.1 | 3.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 3.2 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 14.8 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.1 | 2.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 15.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 1.5 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.1 | 4.2 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.1 | 0.8 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.1 | 1.0 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.1 | 4.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.1 | 1.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.1 | 12.1 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.1 | 17.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 0.5 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.1 | 6.4 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 2.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.1 | 1.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.1 | 0.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.1 | 1.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.1 | 4.6 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 0.5 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
| 0.1 | 1.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.1 | 8.8 | GO:0005604 | basement membrane(GO:0005604) |
| 0.1 | 0.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.1 | 0.7 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.1 | 3.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 1.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.0 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
| 0.0 | 1.7 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.0 | 1.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.0 | 1.0 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.0 | 1.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.0 | 0.2 | GO:0031251 | PAN complex(GO:0031251) |
| 0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.0 | 1.2 | GO:0071437 | invadopodium(GO:0071437) |
| 0.0 | 0.7 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.0 | 0.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.0 | 1.0 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.0 | 5.7 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.0 | 0.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.0 | 1.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.0 | 6.4 | GO:0030426 | growth cone(GO:0030426) |
| 0.0 | 1.7 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.0 | 1.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.0 | 3.8 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.0 | 1.2 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.0 | 0.4 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.0 | 2.1 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 1.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.0 | 0.9 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.0 | 0.1 | GO:0030118 | clathrin coat(GO:0030118) |
| 0.0 | 1.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 1.2 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.0 | 15.6 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 1.0 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.0 | 1.5 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.0 | 0.6 | GO:0005922 | connexon complex(GO:0005922) |
| 0.0 | 1.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.0 | 0.1 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.0 | 0.4 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.0 | 2.9 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.0 | 0.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.0 | 0.4 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.0 | 0.1 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.0 | 0.7 | GO:0034399 | nuclear periphery(GO:0034399) |
| 0.0 | 0.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.0 | 8.9 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.0 | 0.6 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.0 | 0.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
| 0.0 | 0.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.5 | 7.6 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 1.7 | 5.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
| 1.2 | 4.9 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 1.0 | 12.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.9 | 11.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.8 | 3.3 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.8 | 2.4 | GO:0086078 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
| 0.8 | 8.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.7 | 14.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.7 | 2.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.7 | 15.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.7 | 2.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.7 | 9.8 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.6 | 5.6 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.6 | 3.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.6 | 16.7 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.6 | 5.1 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.5 | 3.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
| 0.5 | 1.6 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
| 0.5 | 1.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.4 | 2.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.4 | 1.3 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
| 0.4 | 7.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.4 | 5.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.4 | 2.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.4 | 6.3 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.3 | 1.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.3 | 6.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.3 | 1.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.3 | 1.6 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.3 | 5.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.3 | 3.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.3 | 1.9 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.3 | 2.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.3 | 1.1 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.3 | 1.8 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.3 | 2.0 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.2 | 27.2 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.2 | 13.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.2 | 0.7 | GO:0072544 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
| 0.2 | 2.4 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.2 | 5.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.2 | 4.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.2 | 0.6 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 0.2 | 3.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.2 | 2.1 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.2 | 0.8 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.2 | 2.6 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.2 | 1.0 | GO:0071253 | connexin binding(GO:0071253) |
| 0.2 | 1.5 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.2 | 2.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.2 | 7.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.2 | 9.9 | GO:0042379 | chemokine receptor binding(GO:0042379) |
| 0.1 | 0.6 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.1 | 0.6 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.1 | 1.9 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.1 | 4.8 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 0.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.1 | 0.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.1 | 3.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.1 | 0.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.1 | 3.6 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
| 0.1 | 4.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 1.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.1 | 1.5 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.1 | 2.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.1 | 0.5 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.1 | 1.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.1 | 0.4 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 0.1 | 4.2 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.1 | 2.5 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.1 | 0.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.1 | 2.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.1 | 0.7 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.1 | 0.3 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
| 0.1 | 0.4 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.1 | 1.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 13.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 0.5 | GO:0052842 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.1 | 4.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.1 | 1.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.1 | 0.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 1.9 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.1 | 0.9 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.1 | 0.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.1 | 4.6 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.1 | 1.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 1.8 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.1 | 0.6 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.1 | 9.4 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.1 | 0.4 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.1 | 9.6 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.1 | 1.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.1 | 1.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.1 | 4.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 1.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.1 | 1.2 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.1 | 5.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.1 | 0.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.1 | 2.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.1 | 1.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.1 | 0.2 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.1 | 1.1 | GO:0005537 | mannose binding(GO:0005537) |
| 0.0 | 1.0 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.0 | 0.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.0 | 0.3 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
| 0.0 | 1.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.0 | 2.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.0 | 0.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.0 | 1.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.0 | 1.0 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.0 | 0.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.0 | 0.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.0 | 1.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.0 | 1.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.0 | 1.0 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.0 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.0 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.0 | 7.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 1.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.0 | 0.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.0 | 0.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.0 | 0.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.0 | 0.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.0 | 0.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.0 | 1.1 | GO:0001848 | complement binding(GO:0001848) |
| 0.0 | 0.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.0 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.0 | 0.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.0 | 9.2 | GO:0030674 | protein binding, bridging(GO:0030674) |
| 0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.0 | 2.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 0.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.0 | 0.7 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.0 | 5.5 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.0 | 0.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.0 | 0.5 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 1.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.0 | 1.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 0.9 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.0 | 2.6 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.0 | 13.6 | GO:0003779 | actin binding(GO:0003779) |
| 0.0 | 0.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.0 | 0.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 2.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.0 | 0.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.0 | 2.8 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.0 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.0 | 3.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.0 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.0 | 0.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.0 | 0.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.0 | 0.8 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.0 | 0.4 | GO:0015026 | coreceptor activity(GO:0015026) |
| 0.0 | 1.1 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.0 | 2.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 13.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.3 | 1.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.3 | 11.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.2 | 23.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.2 | 10.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.2 | 6.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.2 | 5.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.2 | 5.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.2 | 8.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.1 | 10.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.1 | 9.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 1.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.1 | 0.9 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.1 | 3.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.1 | 4.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.1 | 10.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 3.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 4.8 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 0.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.1 | 7.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 3.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.1 | 1.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 1.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.1 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.1 | 3.6 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.0 | 3.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.0 | 2.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.0 | 0.6 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.0 | 1.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.0 | 2.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.0 | 1.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.0 | 2.2 | PID ATR PATHWAY | ATR signaling pathway |
| 0.0 | 13.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 2.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.0 | 9.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 1.4 | PID FOXO PATHWAY | FoxO family signaling |
| 0.0 | 2.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.0 | 0.6 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.0 | 0.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.0 | 0.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.0 | 2.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.0 | 7.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.0 | 0.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 0.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.0 | 0.7 | PID BMP PATHWAY | BMP receptor signaling |
| 0.0 | 0.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 2.9 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 14.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.4 | 15.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.3 | 19.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.3 | 3.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.2 | 14.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.2 | 3.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
| 0.2 | 0.7 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.2 | 2.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.2 | 3.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.1 | 5.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.1 | 6.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 3.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 3.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.1 | 7.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.1 | 1.3 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
| 0.1 | 1.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.1 | 6.6 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
| 0.1 | 5.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.1 | 2.4 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
| 0.1 | 1.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.1 | 5.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.1 | 3.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 0.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 1.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.1 | 3.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.1 | 3.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 2.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.1 | 2.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.1 | 2.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.1 | 5.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.4 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.0 | 5.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 4.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 0.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.0 | 10.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 1.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.0 | 0.8 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.0 | 1.4 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
| 0.0 | 1.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.0 | 1.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.0 | 1.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.0 | 0.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.0 | 2.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.0 | 0.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.0 | 0.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.0 | 7.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.0 | 1.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.0 | 2.3 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.0 | 2.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.0 | 0.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.0 | 0.6 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
| 0.0 | 0.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.0 | 0.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.0 | 0.1 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.0 | 0.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.0 | 0.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.0 | 0.6 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
| 0.0 | 0.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 1.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.0 | 0.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.0 | 0.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.0 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.0 | 2.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.0 | 0.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |